UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000006925
Receipt number R000008176
Scientific Title Clinical significance of proteinuria without hypertension during pregnancy
Date of disclosure of the study information 2012/01/01
Last modified on 2014/06/22 07:59:05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical significance of proteinuria without hypertension during pregnancy

Acronym

Clinical significance of proteinuria without hypertension during pregnancy

Scientific Title

Clinical significance of proteinuria without hypertension during pregnancy

Scientific Title:Acronym

Clinical significance of proteinuria without hypertension during pregnancy

Region

Japan


Condition

Condition

Preeclampsia

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Prospective study on the risk of progression to preeclampsia among women with newly onset isolated proteinuria

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The risk of progression to preeclampsia among women with newly onset isolated proteinuria

Key secondary outcomes

1. The risk of progression to preeclampsia among women with newly onset hypertension alone
2. The comparison of clinical courses of women who initially presented with proteinuria alone, hypertension alone, and the both.
3. The characteristics of laboratory variables of participants in this study.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

The participants are pregnant women who are managed at the Hokkaido University Hospital. Women who exhibit proteinuria alone, hypertension alone or the both are eligible and should fulfill all of following three conditions.
1. Antenatal care is given before 20 weeks of gestation.
2. Proteinuria or hypertension is detected first at and after 20 weeks of gestation.
3. Written informed consent is obtained before the participation in this study. If the participant is nonage, the informed consent is obtained from parent.

Key exclusion criteria

1. A pregnant woman who refuses to participate in this study.
2. A pregnant woman who has other complications.
3. A pregnant woman who is considered inappropriate for this study by researchers.

Target sample size

150


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hisanori Minakami

Organization

Hokkaido University Graduate School of Medicine

Division name

Department of Obstetrics, Reproductive and Developmental Medicine, Division of Pathophysiological Science

Zip code


Address

N15W7, Kita-ku, Sapporo, 060-8638, Japan

TEL

011-706-6932

Email



Public contact

Name of contact person

1st name
Middle name
Last name Takahiro Yamada

Organization

Hokkaido University Hospital

Division name

Department of Obstetrics

Zip code


Address

N14W5, Kita-ku, Sapporo, 060-8648, Japan

TEL

011-706-5941

Homepage URL


Email

taka0197@med.hokudai.ac.jp


Sponsor or person

Institute

Department of Obstetrics, Reproductive and Developmental Medicine, Division of Pathophysiological Science, Hokkaido University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Department of Obstetrics, Reproductive and Developmental Medicine, Division of Pathophysiological Science, Hokkaido University Graduate School of Medicine

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2012 Year 01 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 01 Month 01 Day

Date of IRB


Anticipated trial start date

2012 Year 01 Month 01 Day

Last follow-up date

2014 Year 08 Month 01 Day

Date of closure to data entry

2014 Year 09 Month 01 Day

Date trial data considered complete

2014 Year 09 Month 01 Day

Date analysis concluded

2015 Year 03 Month 01 Day


Other

Other related information

Multi institutional prospective study.


Management information

Registered date

2011 Year 12 Month 21 Day

Last modified on

2014 Year 06 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008176


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name